MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.mayocp.2021.08.006

Медицинская библиотека · Mayo Clinic proceedings · 2021

Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy.

Barge-Caballero Gonzalo, Barge-Caballero Eduardo, López-Pérez Manuel, Bilbao-Quesada Raquel, González-Babarro Eva, Gómez-Otero Inés, López-López Andrea, Gutiérrez-Feijoo Mario, Varela-Román Alfonso, González-Juanatey Carlos, Díaz-Castro Óscar, Crespo-Leiro María G

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To investigate a potential association between beta-blocker exposure and survival in patients with transthyretin amyloid cardiomyopathy (ATTR-CM).

METHODS

In this real-world prospective registry of 128 consecutive patients with ATTR-CM recruited in 7 institutions in Galicia (Spain), survival of 65 patients who received beta blockers on registry enrollment was compared with that of 63 untreated controls by means of both unweighted Cox regression and Cox regression with inverse probability of treatment weighting. Tolerance to and adverse effects of beta blockers were recorded. Median study follow-up was 520 days.

RESULTS

Patients with ATTR-CM who received beta blockers showed statistically significant lower all-cause mortality than untreated controls as evaluated by either unweighted Cox regression (hazard ratio, 0.31; 95% CI, 0.12 to 0.79) or Cox regression with inverse probability of treatment weighting (hazard ratio, 0.18; 95% CI, 0.08 to 0.41; P<.001). Several sensitivity analyses confirmed the internal validity of these results. The overall frequency of beta-blocker suspension due to adverse effects was 25% (95% CI, 15.5% to 34.5%).

CONCLUSION

In this real-world, prospective, multi-institutional registry, patients with ATTR-CM who received beta blockers had lower all-cause mortality than untreated controls.

Для цитирования: Barge-Caballero Gonzalo, Barge-Caballero Eduardo, López-Pérez Manuel, Bilbao-Quesada Raquel, González-Babarro Eva, Gómez-Otero Inés, López-López Andrea, Gutiérrez-Feijoo Mario, Varela-Román Alfonso, González-Juanatey Carlos, Díaz-Castro Óscar, Crespo-Leiro María G. Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy.. Mayo Clinic proceedings. 2021. DOI: 10.1016/j.mayocp.2021.08.006.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.